###  [:house:返回首頁](https://github.com/ourhimalayas/txt)
---

## 美《2021战略竞争法》第214节关于中共病毒溯源
` HimalayaRussia` [轉載自GNews](https://gnews.org/zh-hans/1074312/)

俄罗斯莫斯科喀秋莎农场   仰望七星

编辑上传  水星
![]()![](https://www.gnews.org/wp-content/uploads/2021/04/C-9.jpg)sdmayer.com
4月8日，笔者第一时间发文报道了“美参议院将审议‘战略竞争法案’对抗中共”【1】，面对这份280多页的提案，自感能力和精力不足以承担对“重磅提案”的翻译和解读，期待着《路德社》、秘密翻译组，昨晚《路德社》作出了振奋人心的解读，令人回味无穷。

现将提案中涉及中共病毒部分摘译，供战友参考。

第214节. 关于中共病毒疫情起源的报告

（a）国会意识–这是国会意识到的：

（1）了解中共病毒疫情的起源至关重要，这样美国才能更好地准备、预防和应对未来疫情对健康的威胁；

（2）鉴于中共病毒疫情对所有美国人的影响，美国人民理应了解美国政府掌握的有关中共病毒起源的信息；

（3）国会与美国政府以及其他13个外国政府一样，对世界卫生组织派往中共国研究中共病毒起源的国际专家组“严重延误，无法获得完整的原始数据和样本”的事件表示关切；

（4）2021年3月30日，世卫组织总干事特德罗斯·阿达诺姆·盖布雷耶苏斯（Tedros Adhanom Ghebreyesus）博士的声明进一步确认，调查组在获取必要的原始数据时遇到了“困难”，即“我们尚未找到病毒的来源”，“所有假设仍在讨论中”；

（5）对于独立专家来说，充分获取所有相关人、动物和环境数据、活病毒样本、（疫情）爆发早期阶段有关的研究，参与人员，确定这种流行病是如何出现的，这一点至关重要。

（b）所需报告–在本法案颁布后180天内，国家情报总监与国务卿、卫生和公共服务部长、能源部长和其他相关执行部门协调，应向国会拨款委员会提交一份报告，包括：

（1）武汉病毒学研究所（WIV）对中共病毒最可能的来源或起源的评估，包括对美国掌握的所有信息的详细审查，基于美国政府迄今为止的信息，已确定可能与中共病毒的来源或起源有关，包括人畜共患传播和泄露、武汉病毒研究所或其他来源、传播或泄露；

（2）美国政府对中共病毒病因学主要可信理论的鉴定，美国为验证这些理论所采取的步骤，以及美国情报机构、执行机构和执行办公室之间对中共病毒最可能来源或起源的评估或异议的差异，以及此类差异或异议的依据；

（3）描述美国政府为识别和调查中共病毒的来源所采取的所有措施，包括这些努力的时间表；

（4）美国和世卫组织要求提供的数据的详细说明，以及有权接触以确定中共病毒的来源；

（5）以报告形式说明，中共国在调查或审查确定中共病毒的来源和传播方面的配合，阻挠或妨碍的努力，（报告）包括可能的实验室泄露，中共国或中国共产党制造和散播有关病毒来源和传播错误或虚假的信息，包括国家和地方政府以及卫生实体；

（6）美国政府关于武汉病毒研究所及相关设施已知信息的详细说明，包括中共病毒研究活动和功能获得研究、与实验室相关人员的任何疾病报告（症状与中共病毒一致）和最终诊断，以及与中共病毒相关研究的时间表；

（7）中共国任何已知约定的清单，即，在发生中共病毒疫情时中共国需要提供的披露和合作；以及

（8）概述美国与中共国在中共病毒方面的接触，包括：

（A）详细说明美国与武汉病毒研究所，以及中共国类似实验室在中共病毒方面的合作，包括详细说明美国政府赞助的研究和资助，以及外交合作，如“轨道1.5”和“轨道2”合作（笔者注：指个人、团体的“非国家行为”合作方式）；以及

（B）在2017年美国政府暂停资助后，对美国政府资助用于支持在中共国进行功能增益研究的任何额外资金进行评估，以及在暂停资金期间（2014—2017），是否有美国资金被用于中共国的功能增益研究。

（c） 表格——（b）要求的报告应以非保密形式提交，但可包括保密附件。

（d） 定义适当的国会委员会，在本节中，“适当的国会委员会”一词是指：

（1） 参议院外交关系委员会；

（2） 参议院情报特别委员会；

（3） 参议院健康、教育、劳动和养老金委员会；

（4） 参议院军事委员会；

（5） 众议院外交事务委员会；

（6） 众议院情报常设特别委员会；

（7） 众议院能源和商业委员会；以及

（8） 众议院军事委员会

（本章节完）

参考链接：

【1】https://www.gnews.org/zh-hans/1065880/

文字整理：

SEC. 214. REPORT ON ORIGINS OF THE COVID–19 PANDEMIC.

(a) SENSE OF CONGRESS. –t is the sense of Congress that—

(1) it is critical to understand the origins of the COVID–19 pandemic so the United States can better prepare, prevent, and respond to pandemic health threats in the future;

(2) given the impact of the COVID–19 pandemic on all Americans, the American people deserve

to know what information the United States Government possesses about the origins of COVID–19, as appropriate;

(3) Congress shares the concerns expressed by the United States Government and 13 other foreign governments that the international team of experts dispatched to the People’s Republic of China by the World Health Organization (WHO) to study the origins of the SARS–CoV–2 virus was ‘‘significantly

delayed and lacked access to complete, original data and samples’’;

(4) the March 30, 2021, statement by the Director-General of the WHO, Dr. Tedros Adhanom Ghebreyesus, further affirms that the investigative team had encountered ‘‘difficulties’’ in accessing

necessary raw data, that ‘‘we have not yet found the source of the virus,’’ and that ‘‘all hypotheses remain on the table’’; and

(5) it is critical for independent experts to have full access to all pertinent human, animal, and environmental data, live virus samples, research, and personnel involved in the early stages of the out- break relevant to determining how this pandemic emerged.

(b) REPORT REQUIRED. –Not later than 180 days after enactment of this Act, the Director of National Intelligence, in coordination with the Secretary of State, the Secretary of Health and Human Services, the Secretary of Energy, and other relevant executive departments, shall submit to the appropriate committees of Congress a report consisting of–

(1) an assessment of the most likely source or origin of the SARS–CoV–2 virus, including a detailed review of all information the United States possesses that it has identified as potentially relevant to the source or origin of the SARS–CoV–2 virus, including zoonotic transmission and spillover, the Wuhan Institute of Virology (WIV), or other sources of origin, transmission, or spillover, based on the information the United States Government has to date;

(2) an identification of the leading credible theories of the etiology of the SARS–CoV–2 virus by the United States Government, the steps the United States has taken to validate those theories, and any

variance in assessment or dissent among or between United States intelligence agencies, executive agencies, and executive offices of the most likely source or origin of the SARS–CoV–2 virus, and the basis for such variance or dissent;

(3) a description of all steps the United States Government has taken to identify and investigate the source of the SARS–CoV–2 virus, including a timeline of such efforts;

(4) a detailed description of the data to which the United States and the WHO have requested and

have access to in order to determine the origin of the source of the SARS–CoV–2 virus;

(5) an account of efforts by the PRC to cooperate with, impede, or obstruct any inquiry or investigation to determine the source and transmission of SARS–CoV–2 virus, including into a possible lab

leak, or to create or spread misinformation or disinformation regarding the source and trans mission of SARS–CoV–2 virus by the PRC or CCP, including by national and local governmental and health entities;

6) a detailed account of information known to the United States Government regarding the WIV   and associated facilities, including research activities on coronaviruses and gain-of-function research, any reported illnesses of persons associated with the laboratory with symptoms consistent with COVID–19 and the ultimate diagnosis, and a timeline of research relevant to coronaviruses;

(7) a list of any known obligations on the PRC that require disclosure and cooperation in the event of a viral outbreak like SARS–CoV–2; and

(8) an overview of United States engagement with the PRC with respect to coronaviruses that includes—

(A) a detailed accounting of United States engagement with the WIV and similar labs in the PRC specific to coronaviruses, including a detailed accounting United States Government sponsored research and funding and diplomatic engagements such as ‘‘track 1.5’’ and ‘‘track 2’’ engagements; and

(B) an assessment of any additional scrutiny of United States Government funding to support gain-of-function research in the PRC after the moratorium on such funding was lifted in 2017, and whether United States Government funding was used to support gain-of-function research in China, during the moratorium on gain-of-function research (2014–2017).

(c) FORM. –The report required by subsection (b) shall be submitted in unclassified form but may include a classified annex.

(d) APPROPRIATE COMMITTEES OF CONGRESS DEFINED. –In this section, the term ‘‘appropriate committees of Congress’’ means–

(1) the Committee on Foreign Relations of the Senate;

(2) the Select Committee on Intelligence of the Senate;

(3) the Committee on Health, Education, Labor, and Pensions of the Senate;

(4) the Committee on Armed Services of the Senate;

(5) the Committee on Foreign Affairs of the House of Representatives;

(6) the Permanent Select Committee on Intelligence of the House of Representatives;

(7) the Committee on Energy and Commerce of the House of Representatives; and

(8) the Committee on Armed Services of the House of Representatives

0
